PIK3CA and neoplasm: In the current study, PIK3CA mutations were identified in 11 tumours (9.8%) and, more especially, in exon 9 than in exon 20; this observation is in contrast with that observed in the Sartore-Bianchi's et al [21] cohort but in agreement with that reported by Prenen et al [26].